Proactive adoption of generative artificial intelligence (AI) in the operations of Japan's Pharmaceuticals and Medical Devices Agency (PMDA): Current initiatives, governance, and future perspectives

Global Health and Medicine · Published 2026-06-12 · DOI 10.35772/ghm.2026.01046

Free full text

Authors (8)

Kohei Amakasu, Junichi Kawana, Osamu Kotera, Tomoharu Numanyu, Akihiro Nakajima, Koichi Ishikawa, Yuka Kobayashi, Yoshiaki Uyama

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Amakasu, K., Kawana, J., Kotera, O., et al. (2026). Proactive adoption of generative artificial intelligence (AI) in the operations of Japan's Pharmaceuticals and Medical Devices Agency (PMDA): Current initiatives, governance, and future perspectives. Global Health and Medicine. https://doi.org/10.35772/ghm.2026.01046

Related articles